ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 3.805
0.00 (3.81%)
Oct 15, 2026, 3:30 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 23.79 million as of October 15, 2026. It is the 33,729th most valuable company in the world and the 723rd biggest in the United Kingdom. Its market cap has decreased by 54.49% in one year.
Market Cap
23.79M
Enterprise Value
23.10M
Revenue
n/a
Global Rank
Country Rank
#723 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 23.79M, a decrease of -34.12%. That is a compound annual growth rate of -2.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 23.79M | -23.67% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 48.86M |
| Hemogenyx Pharmaceuticals | 48.28M |
| Sareum Holdings | 38.11M |
| Arecor Therapeutics | 36.24M |
| IXICO | 16.97M |
| SkinBioTherapeutics | 14.90M |
| Oxford BioDynamics | 14.79M |